- Home
- HRMY vs BBUC Comparison
HRMY vs BBUC Comparison
Compare HRMY & BBUC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HRMY
- BBUC
- Stock Information
- Founded
- HRMY 2017
- BBUC 2022
- Country
- HRMY United States
- BBUC United States
- Employees
- HRMY N/A
- BBUC N/A
- Industry
- HRMY Biotechnology: Pharmaceutical Preparations
- BBUC
- Sector
- HRMY Health Care
- BBUC
- Exchange
- HRMY Nasdaq
- BBUC Nasdaq
- Market Cap
- HRMY 1.8B
- BBUC 2.2B
- IPO Year
- HRMY 2020
- BBUC N/A
- Fundamental
- Price
- HRMY $34.00
- BBUC $29.78
- Analyst Decision
- HRMY Strong Buy
- BBUC
- Analyst Count
- HRMY 9
- BBUC 0
- Target Price
- HRMY $54.44
- BBUC N/A
- AVG Volume (30 Days)
- HRMY 642.5K
- BBUC 106.6K
- Earning Date
- HRMY 08-05-2025
- BBUC 01-01-0001
- Dividend Yield
- HRMY N/A
- BBUC 0.85%
- EPS Growth
- HRMY 13.13
- BBUC N/A
- EPS
- HRMY 2.62
- BBUC N/A
- Revenue
- HRMY $744,852,000.00
- BBUC $8,309,000,000.00
- Revenue This Year
- HRMY $20.10
- BBUC N/A
- Revenue Next Year
- HRMY $18.01
- BBUC N/A
- P/E Ratio
- HRMY $13.10
- BBUC N/A
- Revenue Growth
- HRMY 20.62
- BBUC 8.15
- 52 Week Low
- HRMY $26.47
- BBUC $19.84
- 52 Week High
- HRMY $41.61
- BBUC $32.47
- Technical
- Relative Strength Index (RSI)
- HRMY 58.91
- BBUC 49.45
- Support Level
- HRMY $31.70
- BBUC $29.62
- Resistance Level
- HRMY $35.08
- BBUC $30.51
- Average True Range (ATR)
- HRMY 0.95
- BBUC 0.83
- MACD
- HRMY 0.27
- BBUC -0.17
- Stochastic Oscillator
- HRMY 71.80
- BBUC 23.47
About HRMY Harmony Biosciences Holdings Inc.
Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.
About BBUC Brookfield Business Corporation Exchangeable Subordinate Voting Shares
Brookfield Business Corp is a company established as a vehicle that owns and operates certain services and industrial operations on a world-wide basis and an alternative vehicle for investors who prefer investing in its operations through a corporate structure. Its goal is to generate returns through long-term capital appreciation with a modest distribution yield.